{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:08:08Z","timestamp":1793315288246,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbcan.2025.189443","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:54:14Z","timestamp":1757375654000},"page":"189443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"1880","author":[{"given":"Xiaolong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangeng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbcan.2025.189443_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0010","first-page":"112","article-title":"American Cancer Society\u2019s report on the status of cancer disparities in the United States, 2021","volume":"72","author":"Islami","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10485","key":"10.1016\/j.bbcan.2025.189443_bb0020","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189443_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189353","article-title":"Breaking the immune desert: strategies for overcoming the immunological challenges of pancreatic cancer","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189443_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040601","article-title":"Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine Chemoresistance in pancreatic Cancer","volume":"13","author":"Amrutkar","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189443_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189443_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2020.07.001","article-title":"Targeting CD73 to augment cancer immunotherapy","volume":"53","author":"Roh","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189443_bb0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/0008-5472.CAN-22-2553","article-title":"CD73-dependent adenosine signaling through Adora2b drives immunosuppression in ductal pancreatic Cancer","volume":"83","author":"Faraoni","year":"2023","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1432-1033.2001.01896.x","article-title":"The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2","volume":"268","author":"Heine","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbcan.2025.189443_bb0055","doi-asserted-by":"crossref","first-page":"1163585","DOI":"10.3389\/fimmu.2023.1163585","article-title":"The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer","volume":"14","author":"Strickland","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189443_bb0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189443_bb0065","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1158\/0008-5472.CAN-06-4249","article-title":"Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling","volume":"67","author":"Raskovalova","year":"2007","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189443_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101649","article-title":"PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies","volume":"5","author":"Basavaraja","year":"2024","journal-title":"Cell Reports Med."},{"issue":"33","key":"10.1016\/j.bbcan.2025.189443_bb0075","first-page":"e2302498","article-title":"Tumor microenvironment responsive CD8(+) T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor AB680-based synergistic therapy for pancreatic cancer","volume":"vol. 10","author":"Chen","year":"2023","journal-title":"Advan. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189443_bb0080","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination Cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.bbcan.2025.189443_bb0085","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1158\/1078-0432.CCR-24-0499","article-title":"A phase Ib\/II randomized clinical trial of Oleclumab with or without Durvalumab plus chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma","volume":"30","author":"Coveler","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"39","key":"10.1016\/j.bbcan.2025.189443_bb0090","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/onc.2010.292","article-title":"Extracellular adenosine triphosphate and adenosine in cancer","volume":"29","author":"Stagg","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189443_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: adenosine in tumor microenvironment","volume":"7","author":"Ohta","year":"2016","journal-title":"Front. Immunol."},{"issue":"6866","key":"10.1016\/j.bbcan.2025.189443_bb0100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189443_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006784","article-title":"Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo","volume":"4","author":"Koeppen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189443_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.849258","article-title":"Purinergic and Adenosinergic signaling in Pancreatobiliary diseases","volume":"13","author":"Faraoni","year":"2022","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/med.20048","article-title":"Progress in the pursuit of therapeutic adenosine receptor antagonists","volume":"26","author":"Moro","year":"2006","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/intimm\/dxad035","article-title":"Metabolic advantages of regulatory T cells dictated by cancer cells","volume":"36","author":"Kondo","year":"2024","journal-title":"Int. Immunol."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189443_bb0125","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-24-2860","article-title":"Pasca di Magliano M, Sherman MH: pancreatic Cancer-associated fibroblasts: where do we go from Here?","volume":"84","author":"Carpenter","year":"2024","journal-title":"Cancer Res."},{"issue":"46","key":"10.1016\/j.bbcan.2025.189443_bb0130","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.3748\/wjg.v27.i46.7956","article-title":"T cells in pancreatic cancer stroma","volume":"27","author":"Goulart","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189443_bb0135","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.pan.2021.03.018","article-title":"Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival","volume":"21","author":"Zhao","year":"2021","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189443_bb0140","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41388-021-02132-6","article-title":"CD73 induces GM-CSF\/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis","volume":"41","author":"King","year":"2022","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189443_bb0145","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","article-title":"Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs","volume":"19","author":"Allard","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189443_bb0150","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-018-2186-0","article-title":"Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models","volume":"67","author":"Leone","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189443_bb0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189443_bb0160","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/0008-5472.CAN-24-1875","article-title":"Adenosine uptake through the nucleoside transporter ENT1 suppresses antitumor immunity and T-cell pyrimidine synthesis","volume":"85","author":"Allard","year":"2025","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008594","article-title":"Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8(+) T cells","volume":"13","author":"Shin","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189443_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149814","article-title":"Feedback activation of CD73-adenosine axis attenuates the antitumor immunity of STING pathway","volume":"708","author":"Fu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189443_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106002","article-title":"Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody","volume":"77","author":"Tej","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189443_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.mcb.2024.07.010","article-title":"Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer","volume":"190","author":"Chowdhury","year":"2024","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189443_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.872017","article-title":"Increased expression of mitochondrial UQCRC1 in pancreatic Cancer impairs antitumor immunity of natural killer cells via elevating extracellular ATP","volume":"12","author":"Cong","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189443_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12103042","article-title":"CD73 overexpression promotes progression and recurrence of papillary thyroid carcinoma","volume":"12","author":"Jeong","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189443_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004592","article-title":"A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models","volume":"10","author":"Tay","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"36","key":"10.1016\/j.bbcan.2025.189443_bb0200","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1073\/pnas.1308209110","article-title":"Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors","volume":"110","author":"Beavis","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189443_bb0205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fmolb.2019.00060","article-title":"Immunometabolic dysfunction of natural killer cells mediated by the hypoxia-CD73 Axis in solid tumors","volume":"6","author":"Chambers","year":"2019","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI128895","article-title":"CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment","volume":"130","author":"Neo","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.bbcan.2025.189443_bb0215","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","article-title":"Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor","volume":"74","author":"Mittal","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0220","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/s41467-023-38578-3","article-title":"Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"97","key":"10.1016\/j.bbcan.2025.189443_bb0225","doi-asserted-by":"crossref","first-page":"36993","DOI":"10.18632\/oncotarget.26435","article-title":"CD39(+) regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function","volume":"9","author":"Ahlmanner","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189443_bb0230","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/2326-6066.CIR-19-0923","article-title":"An IL6-adenosine positive feedback loop between CD73(+) \u03b3\u03b4Tregs and CAFs promotes tumor progression in human breast Cancer","volume":"8","author":"Hu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2025.189443_bb0235","doi-asserted-by":"crossref","first-page":"4093214","DOI":"10.1155\/2019\/4093214","article-title":"Adenosine generated by regulatory T cells induces CD8(+) T cell exhaustion in gastric Cancer through A2aR pathway","volume":"2019","author":"Shi","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40169-019-0226-9","article-title":"Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma","volume":"8","author":"Daniel","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189443_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113892","article-title":"Effects of metabolism upon immunity: targeting myeloid-derived suppressor cells for the treatment of breast cancer is a promising area of study","volume":"147","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"29","key":"10.1016\/j.bbcan.2025.189443_bb0250","doi-asserted-by":"crossref","first-page":"27478","DOI":"10.18632\/oncotarget.4393","article-title":"Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model","volume":"6","author":"Sorrentino","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/mol.113.088567","article-title":"Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production","volume":"85","author":"Ryzhov","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10238-018-0493-6","article-title":"Mast cells and angiogenesis in pancreatic ductal adenocarcinoma","volume":"18","author":"Longo","year":"2018","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11302-020-09701-6","article-title":"Regulation of tumor infiltrated innate immune cells by adenosine","volume":"16","author":"Strakhova","year":"2020","journal-title":"Purinergic Signal"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molimm.2014.12.015","article-title":"Down-regulation of the A3 adenosine receptor in human mast cells upregulates mediators of angiogenesis and remodeling","volume":"65","author":"Rudich","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008922","article-title":"Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189443_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2017.03.026","article-title":"Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine\/paracrine signaling of the adenosine A3 receptor","volume":"397","author":"Gorzalczany","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic Cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115172","article-title":"Metabolic reprogramming of macrophages by PKM2 promotes IL-10 production via adenosine","volume":"44","author":"Toller-Kawahisa","year":"2025","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0295","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.7150\/thno.91119","article-title":"Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment","volume":"14","author":"Deng","year":"2024","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2020.10.021","article-title":"Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma","volume":"74","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189443_bb0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00262-024-03689-3","article-title":"A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis","volume":"73","author":"Lei","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13046-024-03263-w","volume":"44","author":"Cencioni","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41467-019-14060-x","article-title":"CD73 on cancer-associated fibroblasts enhanced by the a(2B)-mediated feedforward circuit enforces an immune checkpoint","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0320","doi-asserted-by":"crossref","first-page":"1940675","DOI":"10.1080\/2162402X.2021.1940675","article-title":"T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancer","volume":"10","author":"O\u2019Connor","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0325","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1038\/s41598-021-91796-x","article-title":"Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer","volume":"11","author":"Tahkola","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0330","doi-asserted-by":"crossref","first-page":"G223","DOI":"10.1152\/ajpgi.00259.2006","article-title":"Upregulation of CD39\/NTPDases and P2 receptors in human pancreatic disease","volume":"292","author":"K\u00fcnzli","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189443_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228781","article-title":"Purinergic signaling in pancreas-from physiology to therapeutic strategies in pancreatic Cancer","volume":"21","author":"Novak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189443_bb0340","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1091\/mbc.E19-03-0136","article-title":"Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling","volume":"30","author":"Shi","year":"2019","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189443_bb0345","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1002\/jcp.27793","article-title":"MRS1754 inhibits proliferation and migration of bladder urothelial carcinoma by regulating mitogen-activated protein kinase pathway","volume":"234","author":"Zhou","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189443_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092280","article-title":"Long non-coding RNAs as potential regulators of EMT-related transcription factors in colorectal Cancer-A systematic review and bioinformatics analysis","volume":"14","author":"Pavli\u010d","year":"2022","journal-title":"Cancers"},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2025.189443_bb0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.semcancer.2022.06.012","article-title":"The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer","volume":"86","author":"Iser","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189443_bb0360","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00109-018-01742-0","article-title":"The distinct role of CD73 in the progression of pancreatic cancer","volume":"97","author":"Zhou","year":"2019","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbcan.2025.189443_bb0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.canlet.2021.07.024","article-title":"CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: a promising target with non-canonical mechanisms","volume":"519","author":"Yu","year":"2021","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1074\/mcp.RA119.001779","article-title":"Upregulation of CD73 confers acquired Radioresistance and is required for maintaining irradiation-selected pancreatic Cancer cells in a mesenchymal state","volume":"19","author":"Nguyen","year":"2020","journal-title":"Mol. Cell. Proteom."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189443_bb0375","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial-mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189443_bb0380","first-page":"e2206335","article-title":"CD73, a promising therapeutic target of diclofenac, promotes metastasis of pancreatic cancer through a nucleotidase independent mechanism","volume":"vol. 10","author":"Liu","year":"2023","journal-title":"Advan. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0385","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40364-023-00500-w","article-title":"Review immune response of targeting CD39 in cancer","volume":"11","author":"Liu","year":"2023","journal-title":"Biomark. Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189443_bb0395","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","article-title":"Targeting CD39 in Cancer reveals an extracellular ATP- and Inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189443_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/biom13111584","article-title":"Namodenoson inhibits the growth of pancreatic carcinoma via deregulation of the Wnt\/\u03b2-catenin, NF-\u03baB, and RAS signaling pathways","volume":"13","author":"Itzhak","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0405","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5086","article-title":"2-cl-IB-MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines","volume":"49","author":"Kotulova","year":"2022","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189443_bb0410","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-21-0802","article-title":"Targeting CD73 with AB680 (Quemliclustat), a novel and potent small-molecule CD73 inhibitor, restores immune functionality and facilitates antitumor immunity","volume":"21","author":"Piovesan","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189443_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.995027","article-title":"Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma","volume":"12","author":"Faraoni","year":"2022","journal-title":"Front. Oncol."},{"issue":"20","key":"10.1016\/j.bbcan.2025.189443_bb0420","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1158\/0008-5472.CAN-17-0707","article-title":"CD73 promotes resistance to HER2\/ErbB2 antibody therapy","volume":"77","author":"Turcotte","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189443_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/biology12020218","article-title":"Targets of immune escape mechanisms in Cancer: basis for development and evolution of Cancer immune checkpoint inhibitors","volume":"12","author":"Dutta","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bbcan.2025.189443_bb0430","doi-asserted-by":"crossref","first-page":"1212209","DOI":"10.3389\/fimmu.2023.1212209","article-title":"Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy","volume":"14","author":"Kurago","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189443_bb0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14656566.2024.2304125","article-title":"An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer","volume":"25","author":"Mahadevia","year":"2024","journal-title":"Expert. Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189443_bb0440","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2020.02.006","article-title":"ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 Axis","volume":"37","author":"Liu","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T21:26:02Z","timestamp":1758144362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0304419X25001854"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189443","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189443"}}